Clinical Trials Browser

Brain Neoplasms, Disease, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Nervous System Diseases, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

NCT02855086 2020-03-31

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Phase 1/2 Terminated

3 enrolled 7 charts

CNS

Brain Neoplasms, Glioma

NCT02546284 2020-02-28

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Phase 1 Completed

15 enrolled

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

NCT00681993 2019-01-22

PBIC

Phase NA Completed

35 enrolled

Breast

Breast Neoplasms

NCT02350712 2018-09-11

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

Phase 1 Completed

15 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT03631836 2018-08-17

MARELLE01

Phase 1 Unknown

34 enrolled

CNS

Glioblastoma

NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Phase 2 Withdrawn

Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

NCT00356460 2014-03-19

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Phase 1 Completed

29 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT00052403 2014-01-16

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00956436 2013-09-16

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Phase 1 Completed

40 enrolled

Gastrointestinal

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00060138 2013-05-15

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Phase 1/2 Completed

Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

NCT00094653 2011-07-11

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Phase 3 Completed

1,783 enrolled 29 charts

Dermatologic

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT00142155 2011-06-27

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Phase NA Completed

300 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT00265928 2008-01-28

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Phase 2 Terminated

46 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Phase 1 Suspended

95 enrolled

LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

ALPINE: Maintenance Letrozole/Abemaciclib

Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

A Study of BND-35 in Participants With Advanced Solid Tumors

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

DeRIVE

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

CRC - PTX

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

CAPTIVE

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

PBIC

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

MARELLE01

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma